Biran N, Zolotov E, Vesole D, Parmar H, Phull P, Doucette K, Roney P, Ahn J, Feinman R, Zenreich J, Anand P, Pace M, Pia AD, DeAgresta B, Biamonte L, Aleman A, Rutanen E, Chappell A, Kumka S, Siegel DS. A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma. Haematologica 2025;110(10):2493-2497; https://doi.org/10.3324/haematol.2024.287053.